The Lobular Breast Cancer Alliance partnered with SHARE Cancer Support to host an advocate-led roundtable discussion on August 28th, 2019. This hour-long webinar features LBCA […]
Educational Recording: Overview of ILC and Advocacy August, 2019 Read More »
The Great Lakes Breast Cancer Symposium (GLBCS) was held May 2 – 4th, 2019 in Columbus Ohio. Three lobular advocates and steering committee members from
Great Lakes Breast Cancer Symposium: Video interviews with researchers, Advocates Read More »
The Lobular Breast Cancer Alliance and SHARE Cancer Support hosted an educational webinar:Â Research Updates on Metastatic Lobular Breast Cancer on November 13, 2019. Lobular
Webinar: Research Updates on Metastatic ILC Read More »
The Lobular Breast Cancer Alliance and SHARE Cancer Support partnered to present an educational presentation May 15th, 2019 entitled Lobular Breast Cancer: Understanding This Subtype
Webinar- Lobular Breast Cancer: Understanding This Subtype and its Treatment Read More »
March, 2019: The Lobular Breast Cancer Alliance (LBCA) joined the Metastatic Breast Cancer Alliance (MBC Alliance) as a non-profit organization member. LBCA will work collaboratively
LBCA joins the Metastatic Breast Cancer Alliance Read More »
Lobular Breast Cancer can be more difficult to see on imaging and scans. It can be harder to detect on mammograms, resulting in later-stage diagnosis
Expert Opinion: Imaging and Lobular Breast Cancer Read More »
The Lobular Breast Cancer Alliance (LBCA) is pleased to partner with SHARE Cancer Support to offer peer support for patients with lobular breast cancer. Patients
LBCA/SHARE Partner to Support ILC Patients Read More »
Leigh Pate of Seattle, WA received the Beth Caldwell Leadership and Advocacy Breakthrough Award. The award was presented at the Northwest Metastatic Breast Cancer Conference
LBCA Founder Receives Leadership Award Read More »
The Lobular Breast Cancer Alliance sent six patient research advocates to the San Antonio Breast Cancer Symposium (SABCS) in December, 2018 and compiled highlights and
ILC Research at SABCS 2018 Read More »
by LBCA Steering Committee member Diane Mapes (aka @double_whammied) Report from ASCO 2019:Â Q & A with Dr. Otto Metzger The 2019 annual meeting of the
Interview: Study highlights differences in Pre-menopausal ILC/IDC Read More »
Study indicates oncoplastic and shave margin surgical techniques for ILC mastectomies reduce repeated surgeries for lobular breast cancer (ILC)
Study: Beneficial Surgical Techniques for ILC Lumpectomies Read More »
The ROLO trial is a targeted therapy clinical trial in the United Kingdom for patients with advanced or metastatic lobular breast cancer. Name of the
ROLO: Targeted Therapy Trial for Advanced ILC Read More »
The Lobular Breast Cancer Alliance (@LobularBCA) made its Twitter debut on a special #BCSM Tweetchat “Understanding Lobular Breast Cancer” on August 13, 2018. The tweets
#BCSM Tweetchat: Freaky, Sneaky ILC Read More »
The GELATO clinical trial was a lobular breast-cancer specific immunotherapy trial investigating the response to an immunotherapy + chemotherapy medication combination. This phase 2 trial
GELATO: Immunotherapy Clinical Trial for ILC Mets Read More »
The 2018 Northwest Metastatic and Lobular Breast Cancer Conference (NWMBCC) was held October 26th and 27th in Seattle WA. It included three patient-oriented educational sessions
ILC Recorded Educational Sessions – NWMBCC 2018 Read More »
"*" indicates required fields